Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study

Authors :: Rosario Palacios MD, PhD
M. Mayorga MD
C. M. González-Domenech PhD
C. Hidalgo-Tenorio MD, PhD
C. Gálvez MD, PhD
L. Muñoz-Medina MD
J. de la Torre MD, PhD
A. Lozano MD
M. Castaño MD
M. Omar MD, PhD
Jesús Santos MD, PhD
Source :: Journal of the International Association of Providers of AIDS Care, Vol 17 (2018)
Publication Year :: 2018
Publisher :: SAGE Publishing, 2018.
Abstract: Objectives: To analyze the efficacy and safety of dolutegravir/rilpivirine (DTG/RPV) in HIV-infected patients who switched from any other antiretroviral therapy (ART). Methods: Open-label, multicenter study including patients who switched to DTG/RPV between February 2015 and February 2016. Efficacy (HIV RNA

Language :: English
ISSN :: 23259582
Volume :: 17
Database :: Directory of Open Access Journals
Journal :: Journal of the International Association of Providers of AIDS Care
Publication Type :: Academic Journal
Accession number :: edsdoj.44115df5f2a41bdae8eccdf8b5a6f9f
Document Type :: article
Full Text :: https://doi.org/10.1177/2325958218760847

Full Text Access

Tools